These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9835530)

  • 1. In vitro activities of ketolide HMR 3647, macrolides, and clindamycin against Coryneform bacteria.
    Martínez-Martínez L; Pascual A; Suárez AI; Perea EJ
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3290-2. PubMed ID: 9835530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activities of ABT-773 against Listeria monocytogenes and coryneform bacteria of clinical interest.
    Conejo Mdel C; Martínez-Martínez L; Pascual A; Suárez AI; Perea EJ
    Antimicrob Agents Chemother; 2003 Apr; 47(4):1403-6. PubMed ID: 12654678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro susceptibilities of aerobic and facultative non-spore-forming gram-positive bacilli to HMR 3647 (RU 66647) and 14 other antimicrobials.
    Soriano F; Fernández-Roblas R; Calvo R; García-Calvo G
    Antimicrob Agents Chemother; 1998 May; 42(5):1028-33. PubMed ID: 9593121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activities of gemifloxacin and five other antimicrobial agents against Listeria monocytogenes and coryneform bacteria isolated from clinical samples.
    Martínez-Martínez L; Joyanes P; Suárez AI; Perea EJ
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2390-2. PubMed ID: 11451706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-vitro activity of levofloxacin, ofloxacin and D-ofloxacin against coryneform bacteria and Listeria monocytogenes.
    Martínez-Martínez L; Pascual A; Suárez AI; Perea EJ
    J Antimicrob Chemother; 1999 Jun; 43 Suppl C():27-32. PubMed ID: 10404334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro antimicrobial activity of HMR 3004 (RU 64004) against erythromycin A-sensitive and -resistant Corynebacterium spp. isolated from clinical specimens.
    Soriano F; Fernández-Roblas R; Calvo R; García-Calvo G; Pardeiro M; Bryskier A
    J Antimicrob Chemother; 1998 Nov; 42(5):647-9. PubMed ID: 9848450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of the new ketolide HMR 3004 compared to an azalide and macrolides against Streptococcus pneumoniae and Haemophilus influenzae.
    Barry AL; Fuchs PC; Brown SD
    Eur J Clin Microbiol Infect Dis; 1997 Oct; 16(10):767-9. PubMed ID: 9405952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Implication of ermX genes in macrolide- and telithromycin-resistance in Corynebacterium jeikeium and Corynebacterium amycolatum].
    Yagüe Guirao G; Mora Peris B; Martínez-Toldos MC; Rodríguez González T; Valero Guillén PL; Segovia Hernández M
    Rev Esp Quimioter; 2005 Sep; 18(3):236-42. PubMed ID: 16369667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro activity of ketolides HMR 3004 and HMR 3647 and seven other antimicrobial agents against Corynebacterium diphtheriae.
    Engler KH; Warner M; George RC
    J Antimicrob Chemother; 2001 Jan; 47(1):27-31. PubMed ID: 11152428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of RU 64004, a new ketolide antibiotic, against gram-positive bacteria.
    Schülin T; Wennersten CB; Moellering RC; Eliopoulos GM
    Antimicrob Agents Chemother; 1997 May; 41(5):1196-202. PubMed ID: 9145901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro activity of the new ketolide antibiotic HMR 3647 against gram-positive bacteria.
    Schülin T; Wennersten CB; Moellering RC; Eliopoulos GM
    J Antimicrob Chemother; 1998 Sep; 42(3):297-301. PubMed ID: 9786468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ketolide antibiotic HMR 3647, a candidate substance for the treatment of systemic and intracerebral infections with Listeria monocytogenes.
    Nichterlein T; Kretschmar M; Hof H
    Zentralbl Bakteriol; 1999 Apr; 289(2):155-64. PubMed ID: 10360316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of telithromycin (HMR 3647) against anaerobic bacteria compared to those of eight other agents by time-kill methodology.
    Credito KL; Ednie LM; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1999 Aug; 43(8):2027-31. PubMed ID: 10428930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of the ketolide telithromycin (HMR-3647) against erythromycin-susceptible and -resistant pneumococci isolated in the UK.
    Johnson AP; Henwood CJ; Tysall L; Warner M
    Int J Antimicrob Agents; 2001 Jul; 18(1):73-6. PubMed ID: 11463530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activities of the ketolide HMR 3647 against recent gram-positive clinical isolates and Haemophilus influenzae.
    Barry AL; Fuchs PC; Brown SD
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2138-40. PubMed ID: 9687424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activities of ketolides HMR 3647 [correction of HRM 3647] and HMR 3004 [correction of HRM 3004], levofloxacin, and other quinolones and macrolides against Neisseria spp. and Moraxella catarrhalis.
    Sáez-Nieto JA; Vázquez JA
    Antimicrob Agents Chemother; 1999 Apr; 43(4):983-4. PubMed ID: 10103218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activity of linezolid and 12 other antimicrobials against coryneform bacteria.
    Gómez-Garcés JL; Alos JI; Tamayo J
    Int J Antimicrob Agents; 2007 Jun; 29(6):688-92. PubMed ID: 17475450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin).
    Barry AL; Fuchs PC; Brown SD
    Antimicrob Agents Chemother; 1998 Apr; 42(4):945-6. PubMed ID: 9559816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activities of the new ketolide antibiotics HMR 3004 and HMR 3647 against Streptococcus pneumoniae in Germany.
    Reinert RR; Bryskier A; Lütticken R
    Antimicrob Agents Chemother; 1998 Jun; 42(6):1509-11. PubMed ID: 9624505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of newer antibiotics against Corynebacterium jeikeium, Corynebacterium amycolatum and Corynebacterium urealyticum.
    Sánchez Hernández J; Mora Peris B; Yagüe Guirao G; Gutiérrez Zufiaurre N; Muñoz Bellido JL; Segovia Hernández M; García Rodríguez JA
    Int J Antimicrob Agents; 2003 Nov; 22(5):492-6. PubMed ID: 14602367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.